<h4>Background</h4>The anaplastic lymphoma kinase (<i>ALK</i>) gene fusion rearrangement is a potent oncogene, accounting for 2-7% of lung adenocarcinomas, with higher incidence (17-20%) in non-smokers. The gene discussed is ALK; the disease is lung adenocarcinoma.